Last reviewed · How we verify
NCT05075889
Utility of ICG in Benign Bone Tumors
EARLY_PHASE1 trial testing Indocyanine Green in Bone Tumor in 2 participants. Completed in 20 April 2022.
20 April 2022
Quick facts
| Lead sponsor | Dartmouth-Hitchcock Medical Center |
|---|---|
| Phase | EARLY_PHASE1 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 2 |
| Start date | 11 November 2021 |
| Primary completion | 20 April 2022 |
| Estimated completion | 20 April 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Indocyanine Green (INDOCYANINE GREEN) — full drug profile →
Conditions studied
- Bone Tumor — all drugs for Bone Tumor →
Sponsor
Dartmouth-Hitchcock Medical Center
Who can join
12 and older, any sex, with Bone Tumor. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Patients with a biopsy-proven benign bone tumor for which standard of care is intralesional operative management will receive a weight-appropriate IV dose of indocyanine green (ICG, FDA-approved) the day prior to surgery during their standard pre-operative clinic visit. On the day of surgery, fluorescence images will be obtained using a non-invasive fluorescence camera.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Current and Future Applications of Fluorescence Guidance in Orthopaedic Surgery.
Streeter SS, Hebert KA, Bateman LM, Ray GS, et al · · 2023 · cited 11× · PMID 36447084 · DOI 10.1007/s11307-022-01789-z
Verify or expand the search:
- PubMed search for NCT05075889
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Indocyanine Green
Trials testing the same drug.
- NCT05038098 — Magnetic Sentinel Lymph Node Mapping in Gastric Cancer · Phase 1 · not yet recruiting
- NCT07254845 — A PROSPECTIVE, SINGLE-CENTERED, ASSESSOR-BLINDED STUDY TO EVALUATE THE CLINICAL EFFICACY OF THE PROPOSED CELL/TISSUE HIS · Phase 1 · not yet recruiting
- NCT06871787 — Near-Infrared Fluorescence Imaging With Indocyanine Green to Evaluate Bowel Anastomoses in Gynecologic Oncology Surgery · Phase 4 · not yet recruiting
- NCT06672224 — Indocyanine Green Fluoroscopy and SPY Angiography for the Assessment of Lymphatic Structure in Breast Cancer Patients at · NA · withdrawn
- NCT06918210 — Indocyanine Green Fluorescence During Fundus First Laparoscopic Cholecystectomy · NA · not yet recruiting
Other recruiting trials for Bone Tumor
Currently open trials in the same condition.
- NCT06171282 — A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Bone and Soft Tissue Tumors · EARLY_PHASE1 · recruiting
- NCT05779670 — Adherence to a Personalized Home Exercise Program in Patients With Bone Tumor Undergoing Lower Extremity Salvage Surgery · recruiting
Other Dartmouth-Hitchcock Medical Center trials
Trials by the same sponsor.
- NCT07325474 — Plan and Protect: Safety Planning for Teens in Rural Emergency Departments · NA · not yet recruiting
- NCT07428629 — Piloting an Insomnia Treatment in Patients With Ulcerative Colitis · NA · not yet recruiting
- NCT06777511 — Advancing Antimicrobial Photodynamic Therapy to Prevent Infection in Osseointegrated Prosthesis Patients · not yet recruiting
- NCT07279116 — ABY-029 Head & Neck Trial · Phase 1 · not yet recruiting
- NCT07063693 — ABY-029 Glioma Trial · Phase 1 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05075889 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Dartmouth-Hitchcock Medical Center
- Last refreshed: 14 May 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05075889.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing